KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $22,356,000 | -35.0% | 821,594 | -26.9% | 0.57% | -40.4% |
| Q1 2015 | $34,407,000 | +8.1% | 1,124,056 | +32.2% | 0.95% | +27.7% |
| Q4 2014 | $31,828,000 | -19.1% | 850,337 | -24.5% | 0.74% | -18.0% |
| Q3 2014 | $39,337,000 | +27.5% | 1,125,854 | +69.9% | 0.91% | +46.8% |
| Q2 2014 | $30,855,000 | +222.6% | 662,842 | +114.1% | 0.62% | +256.6% |
| Q1 2014 | $9,563,000 | -51.7% | 309,592 | -65.2% | 0.17% | -56.5% |
| Q4 2013 | $19,785,000 | – | 889,520 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |